124 related articles for article (PubMed ID: 3849467)
21. Complement genetic markers in schizophrenia: C3, BF and C6 polymorphisms.
Fañanás L; Moral P; Panadero MA; Bertranpetit J
Hum Hered; 1992; 42(3):162-7. PubMed ID: 1511994
[TBL] [Abstract][Full Text] [Related]
22. Properdin factor B and complement factor C4 allotypes in rheumatoid arthritis: results of a follow-up study.
van Zeben D; Giphart MJ; Christiansen FT; Hoetjer M; Meyer EC; Breedveld FC
Hum Immunol; 1992 Feb; 33(2):148-51. PubMed ID: 1563983
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphism of serum proteins and levels of immunoglobulin and complement components in high caste community (Brahmins) of Madhya Pradesh, India.
Papiha SS; Bernal JE; Mehrotra M
Jinrui Idengaku Zasshi; 1980 Mar; 25(1):1-8. PubMed ID: 6901787
[No Abstract] [Full Text] [Related]
24. BF and C3 genetic polymorphisms in Kaingang Indians from southern Brazil.
Guerra LK; Rehfeldt IR; Lima MT; Petzl-Erler ML; de Messias IJ
Hum Hered; 1992; 42(3):153-6. PubMed ID: 1511992
[TBL] [Abstract][Full Text] [Related]
25. Phenotype distribution of the third component of complement (C3) and of the properdin B factor (BF) in children with mumps meningitis.
Hałasa J; Kacprzak-Bergman I; Mańczak M; Schlesinger D
Eur J Immunogenet; 1993 Aug; 20(4):267-71. PubMed ID: 8399122
[TBL] [Abstract][Full Text] [Related]
26. Genetic variants of complement component 3 (C3) in DR4 positive and DR4 negative rheumatoid arthritis.
Thomson W; Dyer PA; Sanders PA; Grennan DM
Ann Rheum Dis; 1986 Apr; 45(4):269-71. PubMed ID: 3486637
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism of factor B (Bf) in Okayama Prefecture, Japan.
Ameno S; Nanikawa R
Acta Med Okayama; 1984 Aug; 38(4):321-4. PubMed ID: 6568079
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants of factor B in a population of Jordan.
Saleh H; Davrinche C; Charlionet R; Rivat C
Hum Hered; 1986; 36(6):405-7. PubMed ID: 3641774
[TBL] [Abstract][Full Text] [Related]
29. Properdin factor B and acute lymphocytic leukemia (ALL).
Budowle B; Acton RT; Barger BO; Blackstock R; Crist W; Go RC; Humphrey GB; Ragab A; Roper M; Vietti T; Dearth J
Cancer; 1982 Dec; 50(11):2369-71. PubMed ID: 6958349
[TBL] [Abstract][Full Text] [Related]
30. Population genetic data on properdin factor B (Bf) in northern Germany.
Püschel K; Schmidt M; Söder R; Brinkmann B
Am J Phys Anthropol; 1979 Feb; 50(2):247-50. PubMed ID: 443359
[TBL] [Abstract][Full Text] [Related]
31. GLO I and Bf phenotype distribution in a West German population sample.
Mauff G; Wachauf P; Schaal KP; Pulverer G
Hum Hered; 1978; 28(6):431-4. PubMed ID: 680704
[TBL] [Abstract][Full Text] [Related]
32. Properdin factor B (Bf) as an exclusion determinate in parentage testing.
Dykes D; Polesky H
Hum Hered; 1980; 30(5):286-90. PubMed ID: 6901514
[TBL] [Abstract][Full Text] [Related]
33. Associations of properdin factor B with melanoma.
Budowle B; Barger BO; Balch CM; Go RC; Roseman JM; Acton RT
Cancer Genet Cytogenet; 1982 Mar; 5(3):247-51. PubMed ID: 6917774
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of factor B (Bf) and C3 component of complement in type 1 (insulin-dependent) diabetes mellitus: BFQO allele observed in a diabetic child.
Staneková D; Niks M; Buc M; Starsia Z; Michalková
Folia Biol (Praha); 1993; 39(3):117-23. PubMed ID: 8157131
[TBL] [Abstract][Full Text] [Related]
35. Bf group system in the Polish population.
Mańczak M
Arch Immunol Ther Exp (Warsz); 1984; 32(4):431-41. PubMed ID: 6570692
[TBL] [Abstract][Full Text] [Related]
36. C3, BF and C4 polymorphisms in Tunisians.
Ayed K; Gorgi Y
Hum Hered; 1990; 40(6):363-7. PubMed ID: 2083950
[TBL] [Abstract][Full Text] [Related]
37. Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy.
Messias-Reason IJ; Urbanetz L; Pereira da Cunha C
Tissue Antigens; 2003 Oct; 62(4):308-12. PubMed ID: 12974797
[TBL] [Abstract][Full Text] [Related]
38. Properdin factor B(Bf) polymorphism in the population of Veneto, Italy.
Crestani C; Caenazzo L; Cortivo P; Scorretti C; Caenazzo C
Z Rechtsmed; 1988; 101(2):81-5. PubMed ID: 3188673
[TBL] [Abstract][Full Text] [Related]
39. HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritis.
Warlow RS; Uko G; Feeney DJ; Kay PH
Exp Clin Immunogenet; 1988; 5(2-3):133-42. PubMed ID: 3272816
[TBL] [Abstract][Full Text] [Related]
40. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
